Cargando…

Hemangioma: Recent Advances

Hemangiomas are common benign vascular tumors that often present in childhood. Diagnosis is based on clinical history, physical examination, and, when unclear, assisted with ultrasound or MRI. While the majority are small, nonproblematic, and can be managed conservatively, some hemangiomas may be as...

Descripción completa

Detalles Bibliográficos
Autores principales: DeHart, Austin, Richter, Gresham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871355/
https://www.ncbi.nlm.nih.gov/pubmed/31807282
http://dx.doi.org/10.12688/f1000research.20152.1
_version_ 1783472420606181376
author DeHart, Austin
Richter, Gresham
author_facet DeHart, Austin
Richter, Gresham
author_sort DeHart, Austin
collection PubMed
description Hemangiomas are common benign vascular tumors that often present in childhood. Diagnosis is based on clinical history, physical examination, and, when unclear, assisted with ultrasound or MRI. While the majority are small, nonproblematic, and can be managed conservatively, some hemangiomas may be associated with underlying syndromes or concerning for visceral involvement. Symptomatic lesions may develop ulceration, bleeding, vision disturbances, functional limitations, or disfigurement. The ideal treatment for a symptomatic hemangioma is often multimodal and may vary depending on the size, location, and proximity to critical structures. Medical treatments include topical beta blockers, oral propranolol, or steroid injections. Surgical resection and laser therapies may be necessary to optimize long term outcomes.
format Online
Article
Text
id pubmed-6871355
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-68713552019-12-04 Hemangioma: Recent Advances DeHart, Austin Richter, Gresham F1000Res Review Hemangiomas are common benign vascular tumors that often present in childhood. Diagnosis is based on clinical history, physical examination, and, when unclear, assisted with ultrasound or MRI. While the majority are small, nonproblematic, and can be managed conservatively, some hemangiomas may be associated with underlying syndromes or concerning for visceral involvement. Symptomatic lesions may develop ulceration, bleeding, vision disturbances, functional limitations, or disfigurement. The ideal treatment for a symptomatic hemangioma is often multimodal and may vary depending on the size, location, and proximity to critical structures. Medical treatments include topical beta blockers, oral propranolol, or steroid injections. Surgical resection and laser therapies may be necessary to optimize long term outcomes. F1000 Research Limited 2019-11-18 /pmc/articles/PMC6871355/ /pubmed/31807282 http://dx.doi.org/10.12688/f1000research.20152.1 Text en Copyright: © 2019 DeHart A and Richter G http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
DeHart, Austin
Richter, Gresham
Hemangioma: Recent Advances
title Hemangioma: Recent Advances
title_full Hemangioma: Recent Advances
title_fullStr Hemangioma: Recent Advances
title_full_unstemmed Hemangioma: Recent Advances
title_short Hemangioma: Recent Advances
title_sort hemangioma: recent advances
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6871355/
https://www.ncbi.nlm.nih.gov/pubmed/31807282
http://dx.doi.org/10.12688/f1000research.20152.1
work_keys_str_mv AT dehartaustin hemangiomarecentadvances
AT richtergresham hemangiomarecentadvances